Examkin

Question

Difficulty: HardPediatric Genetic and Metabolic Disorders

An infant delivered at full term is admitted to the neonatal intensive care unit at 48 hours of life due to progressive lethargy, hypotonia, and Kussmaul respirations. Initial laboratory evaluation reveals a severe high anion gap metabolic acidosis (pH 7.12pH\ 7.12, HCO3− 7 mEq/LHCO_3^{-}\ 7\ mEq/L), hypoglycemia (34 mg/dL34\ mg/dL), and moderate hyperammonemia (420 μmol/L420\ \mu mol/L). The clinical presentation is highly suspicious for an acute metabolic crisis secondary to an inborn error of metabolism, such as an organic acidemia. Arrange the following acute management and diagnostic steps in the most appropriate sequential order of priority for this patient.

  1. 1Discontinue enteral protein feeds and initiate continuous intravenous fluids with high-concentration dextrose.
  2. 2Obtain critical diagnostic metabolic laboratories including quantitative plasma amino acids and urine organic acids.
  3. 3Administer targeted intravenous therapies such as nitrogen scavengers, L-carnitine, and vitamin cofactors.
  4. 4Prepare for and initiate extracorporeal removal of toxic metabolites via hemodialysis.

Answer

The correct sequence begins with immediately halting enteral protein and providing high-concentration IV dextrose, followed by drawing critical baseline diagnostic laboratories, then administering empirical intravenous therapies (scavengers/cofactors), and finally preparing for hemodialysis if medical management is insufficient.
The primary goal in acute metabolic decompensation is to immediately halt the accumulation of toxic metabolites. This is achieved first by discontinuing enteral protein and reversing catabolism with high-dose intravenous glucose, which promotes insulin release and anabolism. Next, critical diagnostic laboratories must be drawn; this is strictly prioritized before specific medical therapies alter the patient's metabolic profile. Once baseline labs are secured, empirical pharmacologic therapies (nitrogen scavengers, carnitine) are administered to assist in biochemical clearance. Finally, if the patient remains critically ill with severe hyperammonemia or refractory metabolic acidosis despite medical therapy, preparation for continuous renal replacement or hemodialysis is the definitive next step for rapid extracorporeal toxin removal.

Step-by-Step Solution

1
Halt exogenous and endogenous protein breakdown.
Discontinuation of feeds and initiation of high-concentration IV dextrose (e.g., D10W).
Reversing the catabolic state and stopping the toxic substrate load is the physiological first priority in an acute metabolic crisis to prevent rapid clinical deterioration.
2
Collect critical baseline diagnostic samples.
Drawing plasma amino acids, acylcarnitine profile, and urine organic acids.
It is essential to secure these diagnostic markers while the patient is acutely symptomatic and specifically before administering targeted therapies that will obscure the biochemical phenotype.
3
Enhance biochemical clearance and conduct a cofactor trial.
Administration of nitrogen scavengers (e.g., sodium benzoate) and cofactors (e.g., L-carnitine).
Once diagnostic labs are drawn, empirical pharmacologic therapies are rapidly given to assist in conjugating and excreting accumulated toxic metabolites while awaiting definitive lab results.
4
Initiate mechanical clearance of toxins.
Preparation and initiation of hemodialysis.
If the patient's severe acidosis or hyperammonemia is refractory to medical management, or if initial levels are immediately life-threatening, hemodialysis provides definitive, rapid extracorporeal toxin removal.

Key Concept

Sequential management priorities in neonatal acute metabolic crisis
Rate this question

Topics

Pediatric Genetic and Metabolic Disorders

More questions from this topic